Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Weisinger J, Bouzid R, Fadlallah J, Barbet C, Provot F, Poullin P, Neel A, Marie M, Rieu V, Kanouni T, Moranne O, Azoulay E, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P; French National Center for Thrombotic Microangiopathies (CNR‐MAT). Weisinger J, et al. Among authors: veyradier a. Am J Hematol. 2024 Dec 12. doi: 10.1002/ajh.27550. Online ahead of print. Am J Hematol. 2024. PMID: 39668454 No abstract available.
Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center.
Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM, Rivière E, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Chauveau D, Veyradier A, Coppo P. Benhamou Y, et al. Among authors: veyradier a. Am J Hematol. 2015 Jun;90(6):E127-9. doi: 10.1002/ajh.23997. Am J Hematol. 2015. PMID: 25740210 Free article. No abstract available.
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study.
Benhamou Y, Paintaud G, Azoulay E, Poullin P, Galicier L, Desvignes C, Baudel JL, Peltier J, Mira JP, Pène F, Presne C, Saheb S, Deligny C, Rousseau A, Féger F, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies. Benhamou Y, et al. Among authors: veyradier a. Am J Hematol. 2016 Dec;91(12):1246-1251. doi: 10.1002/ajh.24559. Epub 2016 Nov 8. Am J Hematol. 2016. PMID: 27643485 Free article. Clinical Trial.
Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.
Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi JM, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, Ojeda-Uribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y. Grall M, et al. Among authors: veyradier a. Am J Hematol. 2017 Apr;92(4):381-387. doi: 10.1002/ajh.24665. Epub 2017 Feb 21. Am J Hematol. 2017. PMID: 28133771 Free article.
Thrombotic thrombocytopenic purpura.
Joly BS, Coppo P, Veyradier A. Joly BS, et al. Among authors: veyradier a. Blood. 2017 May 25;129(21):2836-2846. doi: 10.1182/blood-2016-10-709857. Epub 2017 Apr 17. Blood. 2017. PMID: 28416507 Free article. Review.
Understanding thrombotic microangiopathies in children.
Joly BS, Zheng XL, Veyradier A. Joly BS, et al. Among authors: veyradier a. Intensive Care Med. 2018 Sep;44(9):1536-1538. doi: 10.1007/s00134-018-5059-2. Epub 2018 Jan 24. Intensive Care Med. 2018. PMID: 29368057 Free PMC article. Review. No abstract available.
Pediatric thrombotic thrombocytopenic purpura.
Joly BS, Coppo P, Veyradier A. Joly BS, et al. Among authors: veyradier a. Eur J Haematol. 2018 Oct;101(4):425-434. doi: 10.1111/ejh.13107. Epub 2018 Aug 22. Eur J Haematol. 2018. PMID: 29889319 Review.
208 results